Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Pershing Gold Corporation. (PGLC) Closes Bought Deal Of US$7.8 Million And Private Placement of $6.8M
-
Pershing Gold Closes Bought Deal Of US$7.8 Million And Private Placement Of US$6.8 Million
-
Aerie Pharma (AERI) PT Raised to $77 at Cantor Fitzgerald following FDA approval of Rhopressa
-
ProPhotonix has Achieved ISO9001:2015
-
WellCare Health Plans (WCG) PT Raised to $235 at Cantor Fitzgerald, Defends Equity, Says 'Selloff Overdone'
-
Centene (CNC) PT Raised to $115 at Cantor Fitzgerald Following 'Impressive' 2018 Guidance
-
Newmark Group (NMRK) IPO Opens Flat
-
Pre-Open Movers 12/15: (DDR) (ALNY) (HES) Higher; (TROV) (VSTM) (CSX) Lower (more...)
-
Global Blood Therapeutics (GBT) Says it Priced $100M Common Stock Offering
-
Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering
-
Rosetta Genomics (ROSG) Agrees to Sell Business to Genoptix for $10M
-
Genoptix to Acquire Rosetta Genomics for $10 Million in Cash
-
BGC Partners And Newmark Group Announce Pricing Of Newmark Group Initial Public Offering
-
Form 3 NEWMARK GROUP, INC. For: Dec 14 Filed by: CANTOR FITZGERALD, L. P.
-
After-Hours Stock Movers 12/14: (DDR) (HES) (DISCA) Higher; (VSTM) (APHB) (ORCL) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Rigel Pharmaceuticals (RIGL) at Overweight
-
Global Blood Therapeutics (GBT) Announces Proposed $100M Share Common Offering
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
BGC Partners Updates Terms For Newmark Group IPO Roadshow
-
UPDATE: Corbus Pharmaceuticals (CRBP) PT Raised to $28 at Cantor Fitzgerald
-
Cantor Fitzgerald Remains Sidelined on Teva Pharma (TEVA) Following Announced Restructuring Plan
-
Orchid Island Capital Announces December 2017 Monthly Dividend and November 30, 2017 RMBS Portfolio Characteristics
-
Amarin (AMRN): AHA Showed OTC Fish Oil Inferior to FDA Approved Products and May Have Negative Effects - Cantor Fitzgerald
-
Cantor Fitzgerald Starts Aimmune Therapeutics (AIMT) at Overweight
-
U.S. yields rise as producer price data offsets 30-year auction
-
Colony NorthStar (CLNS) Signs LOI with S2K Regarding Combination With its Broker-dealer, NorthStar Securities
-
Colony NorthStar to Combine Retail Distribution Business with S2K Financial Holdings
-
Coupa Software (COUP) PT Raised to $38 at Cantor Fitzgerald Following 'Successful' Analyst Day
-
Pershing Gold Announces Bought Deal of US$6.8 Million and Private Placement of US$6.8 Million
-
Pershing Gold (PGLC) Announces $6.8M Common Stock and Warrant Bought Deal
-
Pershing Gold Announces Bought Deal of $6.8 Million
-
Revance Announces Closing of Public Offering of Common Stock
-
ProPhotonix Director/PDMR Dealings and Equity
-
Verisk Analytics (VRSK) PT Raised to $108 at Cantor Fitzgerald Following Investor Day
-
bluebird bio (BLUE) PT Raised to $113 at Cantor Fitzgerald, 'Believes in the Science But Not the Valuation'
-
Revance Therapeutics (RVNC) Prices 5.34M Offering of Common Stock at $31/Share
-
Revance Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Exela Technologies (XELA) at Overweight
-
Cantor Fitzgerald Starts Strongbridge Biopharma (SBBP) at Overweight Noting Undervalued Shares
-
Omnicell (OMCL) PT Raised to $60 at Cantor Fitzgerald, 'New Product Announcements Improve Growth Outlook'
-
Heron Therapeutics (HRTX) Prices $150M Common Stock Offering
-
Heron Therapeutics Announces Pricing of Public Offering of Common Stock
-
ProPhotonix Announces Application for Block Admission
-
Heron Therapeutics (HRTX) Plans Public Offering of Common Stock
-
Heron Therapeutics Announces Public Offering of Common Stock
-
BGC Partners (BGCP) Announces Launch of Newmark Group (NMRK) IPO Roadshow
-
BGC Partners Announces Launch Of Newmark Group IPO Roadshow
-
Northern Trust Appoints Head of ETF Capital Markets for FlexShares
-
Freddie Mac Prices $637 Million Seniors Housing Multifamily K Certificates
-
McEwen Mining Announces Timmins Exploration Program and Funding

